- Home
- GIFT vs LTRN Comparison
GIFT vs LTRN Comparison
Compare GIFT & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFT
- LTRN
- Stock Information
- Founded
- GIFT 1999
- LTRN 2013
- Country
- GIFT United States
- LTRN United States
- Employees
- GIFT N/A
- LTRN N/A
- Industry
- GIFT Catalog/Specialty Distribution
- LTRN Biotechnology: Pharmaceutical Preparations
- Sector
- GIFT Consumer Discretionary
- LTRN Health Care
- Exchange
- GIFT Nasdaq
- LTRN Nasdaq
- Market Cap
- GIFT 37.1M
- LTRN 33.7M
- IPO Year
- GIFT N/A
- LTRN 2020
- Fundamental
- Price
- GIFT $1.03
- LTRN $3.69
- Analyst Decision
- GIFT
- LTRN Hold
- Analyst Count
- GIFT 0
- LTRN 1
- Target Price
- GIFT N/A
- LTRN N/A
- AVG Volume (30 Days)
- GIFT 87.0K
- LTRN 68.3K
- Earning Date
- GIFT 02-15-2025
- LTRN 03-17-2025
- Dividend Yield
- GIFT N/A
- LTRN N/A
- EPS Growth
- GIFT N/A
- LTRN N/A
- EPS
- GIFT N/A
- LTRN N/A
- Revenue
- GIFT $86,439,146.00
- LTRN N/A
- Revenue This Year
- GIFT N/A
- LTRN N/A
- Revenue Next Year
- GIFT N/A
- LTRN N/A
- P/E Ratio
- GIFT N/A
- LTRN N/A
- Revenue Growth
- GIFT N/A
- LTRN N/A
- 52 Week Low
- GIFT $0.50
- LTRN $2.79
- 52 Week High
- GIFT $4.55
- LTRN $11.99
- Technical
- Relative Strength Index (RSI)
- GIFT N/A
- LTRN 52.87
- Support Level
- GIFT N/A
- LTRN $3.45
- Resistance Level
- GIFT N/A
- LTRN $3.97
- Average True Range (ATR)
- GIFT 0.00
- LTRN 0.46
- MACD
- GIFT 0.00
- LTRN -0.00
- Stochastic Oscillator
- GIFT 0.00
- LTRN 37.00
About GIFT RDE Inc. Common Stock
Giftify Inc through its wholly-owned subsidiary, has been in the business of connecting digital consumers, businesses and communities with dining and merchant deal options throughout the United States. The company connects digital consumers, businesses, and communities offering dining and merchant deal options nationwide restaurants, and retailers to customers. The Company buys merchant gift cards from the general public and distributors at a discount and then resells them at a markup.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.